Donate COVID-19 Plasma
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma.
Featured Topics
![New Era for Smarter Food Safety](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/20200304_NewEra_Feature_1600x900.png?itok=kdp_BAKp)
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
![Science-related icons juxtoposed on a background of prescription paperwork](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/Drug_Pricing.jpg?itok=J8A4aGeQ)
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
![Closeup shot of a nurse holding a patient's hand in comfort in a hospital](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/nurse-holding-patients-hand-1001423826.jpg?itok=YK0c-Jyy)
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Aug 01
Thomson International Inc. Conducts Voluntary Recall of Red, Yellow, White, and Sweet Yellow Onions Because of Possible Salmonella Risk
Food & Beverages
Jul 31
SmithFoods Inc. Issues Allergy Alert on Undeclared Cashew Allergen in Earth Grown Vegan Non Dairy Almond Based Frozen Desserts
Food & Beverages
Jul 31
LABORATORIOS JALOMA S.A. de C.V. Issues Voluntary Recall of the Jaloma Antiseptic Hand Sanitizer Due to the Potential Presence of Undeclared Methanol
Drugs
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![stylized illustration of lab workers in white coats manipulating high-tech medical product manufacturing equipment](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/advanced-manufacturing-medical-products-2020-FDA-Voices-1600x900-01.png?itok=dj2xvdgk)
Investing in Advanced Manufacturing to Support Public Health Preparedness
For the past several years, the U.S. Food and Drug Administration has sought to encourage and facilitate the adoption of Advanced Manufacturing.
![young female doctor talking to her young female patient](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/Doctor-Patient-iStock1254406842_1600x900.png?itok=wn2NBe7U)
Potential Risks of Treatment with Unapproved Regenerative Medicine Products
FDA is providing resources to help consumers understand the risks associated with unapproved stem cell, exosome, and products marketed as regenerative medicine.
![collage with three photos showing woman being tested for the coronavirus with a nasal swab, lab scientist wearing full personal protective gear preparing test sample with pipet, and a 3D illustration of the coronavirus](/web/20200803210431im_/https://www.fda.gov/files/styles/medium_3/public/Coronavirus-Tests-FDA-Voices-1600x900-02.png?itok=JkB2NX6F)
FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
FDA's actions are providing stakeholders with more accurate information about diagnostic test performance and allowing for the rapid availability of new tests.
Recently Published Guidances
Jul 31
Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans
Biologics, Drugs
Jul 31
CPG Sec. 280.110- Microbiological Control Requirements-Licensed Anti-Human Globulin and Blood Grouping Reagents
Biologics, Medical Devices
Jul 31
CPG Sec. 280.100 - Stability Requirements - Licensed In Vitro Diagnostic Products
Biologics, Medical Devices